Veterinarians will need to limit prescription charges to a maximum of £21 and be transparent about treatment expenses to safeguard pet owners from exorbitant bills. Starting later this year, practices will be required to disclose price lists and indicate if they are part of a larger chain, as per new legally mandated regulations by the Competition and Markets Authority.
The crackdown by the CMA comes in response to widespread outcry from pet owners over escalating costs. The CMA’s final report supports these concerns, revealing that the average cost of veterinary services surged by 63% between 2016 and 2023, outpacing inflation.
The pet industry, valued at £6.7 billion annually, has flourished due to increased pet ownership, advancements in medical treatments, and the trend of anthropomorphizing animals. This translates to an average of £390 per household with pets. Notably, certain procedures like cruciate ligament surgery for dogs can cost up to £5,000.
The consolidation of independent vet practices by large corporations over the past decade has resulted in six major groups now controlling over 60% of the market, compared to 10% in 2013. The top players, including IVC, CVS, Linnaeus, Medivet, Pets at Home, and VetPartners, are owned by private equity firms. However, the CMA found that independent practices generally charge lower prices compared to corporate groups. It also noted that acquisitions by large entities often lead to inflated prices at the acquired practices, with some groups generating substantial profits compared to costs.
Under the new rules, fees for written prescriptions will be capped at £21 for the initial medication and £12.50 for each additional one, a significant reduction from the current charges that can exceed £30 per prescription. Vets will be required to display comprehensive price lists for standard services, such as consultations, routine procedures, and diagnostics, addressing the current lack of pricing information on many practice websites. Additionally, practices must furnish written estimates in advance for treatments expected to cost £500 or more, a practice currently followed by less than half of all practices.
These reforms stem from significant feedback from the public and industry stakeholders, according to the CMA. Martin Coleman, Chair of the independent Inquiry Group, emphasized the impact of the reforms on pet owners seeking affordable and transparent veterinary care. The changes aim to enhance transparency around practice ownership, pricing, and treatment options, while also establishing oversight by an independent regulator to uphold standards and protect clinical decisions from commercial pressures.
Sue Davies, head of consumer rights policy at Which?, praised the CMA’s actions for promoting trust and reliability in veterinary services, particularly during critical moments when pet owners require immediate treatment. While acknowledging the limitations of the CMA’s scope, Davies highlighted the ongoing need for comprehensive reforms in the veterinary sector to ensure robust regulation and effective redress mechanisms.
Dr. Rob Williams, President of the British Veterinary Association, lauded the CMA’s measures for enhancing transparency, enabling informed decision-making by pet owners, and fostering healthy competition in the industry. Williams noted that the rising costs in veterinary medicine are influenced by various factors, including increased operational expenses and evolving medical technologies that offer advanced treatment options for animals, reflecting the growing expectations of pet owners for high-quality healthcare for their pets.